As the largest pharmaceutical B Corp, Chiesi is serious about behaviour change. We believe protecting patient health and the environment should not be a matter of compromise.
With the decision to change our legal status to a Benefit Corporation,9 Chiesi has made sustainability contractual and legally binding, by incorporating a double purpose for the creation of shared value, and therefore to generate value for its business and for society and the environment.
Moreover: by achieving B Corp certification,10 measuring and reporting both our positive and negative impact transparently and amplifying it throughout our value chain through the Code of Interdependence11, Chiesi is going far beyond carbon reduction.
We consider our sustainability journey as an ongoing process, we are always improving and setting tougher goals.12
In March 2021, Chiesi joined the B Corp Climate Collective (BCCC), committing to the United Nations Framework Convention on Climate Change (UNFCCC) “Race to Zero”. This is a global campaign to rally leadership and support from businesses, cities, regions, investors for a greener future. The objective is to build momentum around the shift to a decarbonised economy.
That’s why we will not only reduce our environmental footprint by managing our operations but by rethinking and innovating our products – for patients and planet.
We are proud to have taken decisive and ambitious action to ensure patients can continue to access the therapeutic options that best suit their needs, whilst innovating to find the most environmentally conscious solution available.13 Patients should not have to shoulder the burden of environmental responsibility when considering treatment options that affect their health.
In the face of a global climate crisis, we must all share the burden of action.